NanoViricides's Broad-Spectrum Antiviral Drug Candidate for the[...]
NanoViricides Has Filed Quarterly Report for Period Ending December 31,[...]
02/23/2021 | Press release | Distributed by Public on 02/23/2021 15:20
Please select the service you want to use:
Smartlinks | Nautilus Inc. | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Shareholders | Internal Dealings | Sports | Sporting Goods Manufacturers and Distributors | New York Stock Exchange (NYSE) | Börse Frankfurt | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | NYSE American | NYSE ARCA Equities | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | Investors Exchange (IEX) | NYSE Chicago
Back
Copyright ©2006-2021 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact